SpringWorks Therapeutics Eulerpool News

SpringWorks Therapeutics Eulerpool News

SpringWorks Therapeutics Aktie News

SpringWorks Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten SpringWorks Therapeutics News stellen wir hier zusammen.

• 5. September ·

  Yahoo
  SpringWorks Therapeutics Inc (SWTX) CEO Saqib Islam Sells 49,000 Shares
• 4. September ·

  TipRanks
  Springworks Therapeutics: Promising Outlook for Ogsiveo Drives Overweight Rating and Elevated Price Target
• 4. September ·

  Thefly.com
  SpringWorks Therapeutics price target raised by $4 at JPMorgan, here's why
• 29. August ·

  SeekingAlpha
  Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q2 2024 Update
• 28. August ·

  Seeking Alpha
  FDA accepts SpringWorks' application for mirdametinib for NF1-PN
• 28. August ·

  Yahoo
  FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• 28. August ·

  Seeking Alpha
  FDA accepts SpringWorks application for mirdametinib for NF1-PN
• 28. August ·

  TipRanks
  Buy Rating Affirmed for Springworks Therapeutics on Strong Outlook for Mirdametinib
• 28. August ·

  GlobeNewswire
  FDA Grants Priority Review to SpringWorks Therapeutics? New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN
• 28. August ·

  Thefly.com
  SpringWorks Therapeutics: FDA grants priority review to NDA for mirdametinib